Breadcrumb

CORE News

Michael S. Kramer awarded the Prix du chercheur émérite 2020-2021 by the RRSPQ

The RI-MUHC senior scientist will present a seminar on “Maternal and child population health...

TB and COVID-19, a joint battle?

On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.

Spotlight paper in World Journal of Hepatology: Alshaima Al Hinai

Recognition for former RI-MUHC trainee’s work on nonalcoholic fatty liver disease

Fall 2021 CIHR competition results

RI-MUHC teams received $9.5 million in project funding

A clear picture of the cost and efficacy of COVID-19 outpatient treatments

In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...

Three RI-MUHC research projects funded in special CIHR calls

Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence

RI-MUHC researchers are successful co-leaders in “100 years of insulin” funding call

Pan-Canadian team receives financing to develop a national pediatric diabetes registry

Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States

Recruitment of first U.S.-based patients in dapsone trial has started

Explore news and events at the RI-MUHC